Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication

Veronica Ojetti, Maria Assunta Zocco, Giovanni Cammarota, Antonio Gasbarrini, Simona Di Caro, Filippo Cremonini, Marcello Candelli, Andrea Lupascu, F Bartolozzi, Ec Nista

Risultato della ricerca: Contributo in rivistaArticolo in rivista

51 Citazioni (Scopus)

Abstract

Moxifloxacin is a broad spectrum fluoroquinolone with single daily administration, currently used, above all, for respiratory tract infections.
Lingua originaleEnglish
pagine (da-a)527-532
Numero di pagine6
RivistaALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume16
Stato di pubblicazionePubblicato - 2002

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Bacterial Agents
  • Aza Compounds
  • Clarithromycin
  • Drug Combinations
  • Fluoroquinolones
  • Helicobacter Infections
  • Helicobacter pylori
  • Omeprazole
  • Patient Compliance
  • Quinolines
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication'. Insieme formano una fingerprint unica.

Cita questo